NACGGANAAA (SEQ ID NO: 1), where N is a modified nucleoside base, and the stem includes at least 3 nucleotide base-pairs and one of the nucleotides in the stem includes a modified nucleoside base, wherein the modified nucleoside base has the structure -B-L-A where A is a branched-chain Man9 oligosaccharide, L is a linker molecule, and B is independently a pyrimidine or pyridine base linked to the sugar-phosphate backbone of the oligonucleotide. Immunogenic conjugates that include the oligonucleotide, and pharmaceutical compositions that include the oligonucleotide or the immunogenic conjugate are also disclosed. Various method of using the oligonucleotides, immunogenic conjugates, and pharmaceutical compositions are also disclosed."/>
公开/公告号US2019117748A1
专利类型
公开/公告日2019-04-25
原文格式PDF
申请/专利权人 BRANDEIS UNIVERSITY;
申请/专利号US201716092137
申请日2017-04-06
分类号A61K39;C12N15/117;C07H15/22;A61K39/39;C12N15/115;A61P31/18;
国家 US
入库时间 2022-08-21 12:08:20